Rat transferrin or-asialotransferrin doubly radiolabelled with 59Fe and 1251 was injected into rats. A determination ofextrahepatic and hepatic uptake indicated that asialotransferrin delivers a higher fraction of the injected 59Fe to the liver than does transferrin. In order to determine in vivo the intrahepatic recognition sites for transferrin and asialotransferrin, the liver was subfractionated into parenchymal, endothelial and Kupffer cells by a low-temperature cell isolation procedure. High-affinity recognition of transferrin (competed for by an excess of unlabelled transferrin) is exerted by parenchymal cells as well as endothelial and Kupffer cells with a 10-fold higher association (expressed per mg of cell protein) to the latter cell types. In all three cell types iron delivery occurs, as concluded from the increase in cellular 59Fe/1251 ratio at prolonged circulation times of transferrin. It can be calculated that parenchymal cells are responsible for 50-60% of the interaction of transferrin with the liver, 20-30% is associated with endothelial cells and about 20% with Kupffer cells. For asialotransferrin a higher fraction of the injected dose becomes associated with parenchymal cells as well as with endothelial and Kupffer cells. Competition experiments in vivo with various sugars indicated that the increased interaction of asialotransferrin with parenchymal cells is specifically inhibited by N-acetylgalactosamine whereas mannan specifically inhibits the increased interaction of asialotransferrin with endothelial and Kupffer cells. Recognition of asialotransferrin by galactose receptors from parenchymal cells or mannose receptors from endothelial and Kupffer cells is coupled to active 59Fe delivery to the cells. It is concluded that, as well as parenchymal cells, liver endothelial and Kupffer cells are also quantitatively important intrahepatic sites for transferrin and asialotransferrin metabolism, an interaction exerted by multiple recognition sites on the various cell types.
INTRODUCTION
All cells require iron, and the physiological apparatus for iron delivery utilizes a serum glycoprotein, transferrin (Aisen & Listowsky, 1980) . About 10% of iron bound to plasma transferrin is destined for the liver (Pollycove & Mortimer, 1961) . With many cell types it has been shown that the acquisition of iron requires the expression of cell-surface transferrin receptors to which the iron-loaded protein binds. Subsequently endocytosis of the irontransferrin complex occurs and iron is removed. In striking contrast with many other endocytosed ligands, transferrin is not degraded (Karin & Mintz, 1981; Octave et al., 1981) and remains bound to its receptor until the receptor rejoins the plasma membrane and releases the apotransferrin (Karin & Mintz, 1981; Octave et al., 1981) . This unique mechanism of receptor-mediated endocytosis has been derived from studies with cells in culture, such as K562 cells (Van Renswoude et al., 1982) , Hep G2 cells (Ciechanover et al., 1983) and isolated rat hepatocytes (Young et al., 1985) and recently in a perfused liver system (Morgan et al., 1986) . A number of groups, however, concluded that receptor-mediated endocytosis does not occur in hepatocytes and that iron uptake occurs by alternative processes such as pinocytosis (Grohlich et al., 1979; Page et al., 1984) , diffusion (Page et al., 1984) or removal of iron from transferrin at the plasma membrane (Cole & Glass, 1983; Veldman et al., 1986) . Moreover, the presence of any transferrin receptors on isolated hepatocytes has been questioned, and iron uptake by the liver has been described as a function of endothelial liver cells (Soda & Tavassoli, 1984; Kishimoto & Tavassoli, 1985) .
Recently some of us established a system to determine the receptor-dependent interaction of ligands with-the various liver cells in vivo (Nagelkerke et al., 1983; Van Berkel et al., 1985a) . After injection of radiolabelled ligands in vivo, a liver perfusion at a low temperature is started (8°C), a liver lobule is tied off to determine the total liver uptake, and subsequently cell separation and purification procedures are performed at 8°C in order to determine the association of radioactivity with parenchymal, Kupffer and endothelial liver cells (Nagelkerke et al., 1983; Van Berkel et al., 1985a,b) . The low temperature isolation method enables the quantitative recovery of radioactivity cell-associated in vivo, in the purified cell fraction. In the present experiments this system is utilized to determine the high-affinity interaction of doubly labelled 59Fe/1251 rat transferrin with the various liver cells in vivo. Furthermore, rat asialotransferrin, a glycoprotein with terminal galactose residues, was used as a control ligand because it was expected that asialotransferrin would interact specifically with galactose receptors from hepatocytes (Ashwell & Morell, 1974) . Because transferrin was reported to interact specifically with endothelial cells, at least in vitro (Soda & Tavassoli, 1984; Kishimoto & Tavassoli, 1985) , a direct comparison should allow a determination of their different cellular destination.
MATERIALS AND METHODS

Chemicals
Metrizamide was obtained from Neyegaard A/S, Oslo, Norway. Collagenase type I, albumin (fraction V, defatted), mannan, N-acetyl-D-galactosamine and Nacetyl-D-glucosamine were purchased from Sigma. 1251 and 1311 (carrier free) in NaOH were purchased from New England Nuclear Chemicals, Dreieich, Germany, Ham's F-10 medium was from Gibco-Europe, Hoofddorp, The Netherlands. Isolation and labelling of transferrin and asialotransferrin Rat transferrin was isolated from serum as described (Van Eijk & Van Noort, 1976) . Rat asialotransferrin was prepared on a column containing neuraminidase immobilized by binding to CNBr-treated Sepharose. Desialylation was checked by sialic acid analysis and isoelectric focusing (Dekker et al., 1985) . Radiolabelling of (asialo)transferrin with 1251 and 59Fe to the diferric state was performed as described (Dekker et al., 1985) .
Serum clearance and liver association in vivo
Throughout this study 12-week-old male Wistar rats were used. Rats were anaesthetized by intraperitoneal injection of 20 mg of Nembutal. The abdomen was opened, and radiolabelled compounds were injected into the inferior vena cava at the level of the renal veins. The body temperature of the rats was monitored as the rectal temperature and maintained at 36.5-37°C by an i.r. heating lamp. At the indicated times, 0.2 ml of blood was taken from the inferior vena cava at least 2 cm distal of the injection point. The samples were centrifuged for 2 min at 20 000 g, and the radioactivity in the supernatants was counted. Liver perfusion was started at the indicated times. After weighing the lobule and counting its radioactivity, the total liver uptake was calculated by using the assumption that 3.75% of the total body weight is contributed by the liver (Nagelkerke et al., 1983) . Cell isolation procedures Rats were anaesthetized and injected with the radiolabelled compounds in a similar way as for the determination of the total liver uptake. At the indicated times after injection the vena porta was cannulated, and a liver perfusion was started with Hanks' buffer, pH 7.4, plug Hepes (2.4 g/l) at 8 'C. After 8 min of perfusion (flow rate 14 ml/min), a lobule was tied off for determination of the total liver uptake. In order to separate the various cell types the liver was subsequently subjected to a low temperature (8°C) perfusion with inclusion of 0.05% (w/v) collagenase. The separation of parenchymal cells was performed at 8 'C as described (Nagelkerke et al., 1983) .
A further subdivision of the non-parenchymal cell preparation into endothelial cells and Kupffer cells was performed by centrifugal elutriation exactly as described Liver earlier (Nagelkerke et al. 1983 ). The total cell isolation procedure is schematically shown in Fig. 1 . As found earlier (Harkes & Van Berkel, 1984; Van Berkel et al., 1985a,b; Nagelkerke et al., 1984 Nagelkerke et al., , 1986 ) with other protein substrates, nio loss of cell-bouna or formation of acid-soluble radioactivity occurred from the 125I-labelled (asialo)transferrin during the low temperature cell isolation procedures, leading to a quantitative recovery of the radioactivity associated with total liver in the subsequently isolated cells. This was checked for each individual cell isolation by comparing the calculated (from the relative contribution of the various cell types) and determined total liver association (recovery percentages varied betwen 92 and 104%). The recovery of 59Fe both from transferrin and asialotransferrin in the isolated cells was significantly lower than the apoprotein (cf Figs. 3 and 5), with percentages ranging from 47 to 62 % at 5 min after injection, 37 to 42% at 30 min and 27 to 31 % at 120 min after injection. Calculation of the contribution of the different cell types to total liver uptake was performed as described (Nagelkerke et al., 1983) . The purity ofthe cell preparations was furthermore routinely checked light-microscopically after staining for peroxidase and by determination of the distribution of the isoenzymes of pyruvate kinase. Tissue uptake of (asialo)transferrin At 30 min after injection of the (asialo)transferrin into rats the tissues were removed, weighed and the amount of radioactivity was determined.
RESULTS
Tissue distribution of transferrin and asialotransferrin
In order to define the tissue specificity of iron uptake from transferrin and asialotransferrin, the percentage of the injected dose associated with various organs and tissues was determined after 30 min of circulation (Figs. 2a and 2b) . Only the liver, spleen and bone marrow showed an increased 59Fe/125I ratio as compared with the administered transferrin. The highest ratio is found in bone marrow (-20) . After injection of doubly labelled asialotransferrin a similar uptake pattern is obtained as with transferrin, with however a clearcut increase in uptake by the liver (2-fold).
The time-dependent accumulation in the liver of 59Fe either transported by transferrin or asialotransferrin (Fig. 3) , indicates that uptake is already significant 30 min after injection [in these experiments the liver was perfused at a low temperature (8°C), so that the contribution of the blood compartment (approx. 90% of the serum value) (Van Berkel et al., 1985a) , is avoided]. From the disparity in the serum decay of 1251-transferrin and 59Fe it is evident that at 15 min after injection iron delivery must already have occurred (Fig. 3) . While the 1251-transferrin radioactivity in serum for transferrin and asialotransferrin is comparable, a higher fractional catabolic rate of 59Fe from asialotransferrin is noticed, which can be accounted for by the higher fractional uptake in the liver. Cellular distribution of (asialo)transferrin in liver
In order to evaluate the cell isolation system as presented in Fig. 1 , the cellular uptake of 125I-asialofetuin in the absence and presence of an excess of unlabelled asialofetuin was determined (Fig. 4) . At 10 min after injection 77 + 3% ( + S.E.M., n = 3) of the injected dose is present in the liver. Cell-association of 125I-asialofetuin to Kupffer and endothelial cells is about 3-fold higher when expressed per mg of cell protein. Taking into account the amount of protein contributed by each cell type to total liver, the proportion of the total liver uptake of asialofetuin for which each cell type is responsible can be calculated (Nagelkerke et al., 1983 125I-asialofetuin (9,ug) was injected into anaesthetized rats, which were preinjected at -1 min with 5 mg of asialofetuin (B), 25 mg of asialofetuin (C) or the solvent only (A). At 10 min after injection of 125I-asialofetuin a liver perfusion was started, and the total liver association (after an 8 min perfusion at 8°C) and the association with the subsequently isolated parenchymal, endothelial and Kupffer cells were determined. When bars are indicated, these represent S.E.M. (n = 3).
The association of 1251-transferrin to the liver is exerted by parenchymal cells as well as endothelial and Kupffer cells (Fig. 5) , Surprisingly, for '25I-asialotransferrin as compared to transferrin, a higher fraction of the injected dose becomes cell-associated to all three cell types. At short times after injection, the specific activity (expressed per mg of cell protein) of 1251-transferrin or '25I-asialotransferrin is about 10-fold higher in endothelial or Kupffer cells as compared with parenchymal cells (see also Fig. 6 ). At prolonged circulation times this factor is even higher (15) (16) (17) (18) (19) (20) . Recalculation of specific activities to relative contribution to total liver uptake ( Effect of asialofetuin and unlabelled transferrin The role of high-affinity sites for transferrin in the interaction of transferrin with the various liver cells was explored by injection of an excess of unlabelled transferrin 2 min before the labelled ligand. At 5 min after injection of 1251-transferrin the cells were isolated and the cell-associated radioactivity was determined (Fig. 6) . The association of 1251-transferrin with parenchymal, endothelial as well as Kupffer cells is similarly inhibited by an excess of unlabelled transferrin.
Preinjection of 25 mg of asialofetuin inhibited the association of 1251-asialotransferrin with the various liver cells to an interaction value which is identical with that for the sialylated transferrin.
Effect of GaINAc, GIcNAc and mannan
The sugar specificity of the cell-association of 1251-asialofetuin and 1251-asialotransferrin was investigated by preinjection of sugar competitors. Preinjection of GalNAc blocked the uptake of '251-asialofetuin into parenchymal cells nearly completely (Fig. 7) . In contrast, the association with endothelial or Kupffer cells was unaffected by GalNAc, while preinjection of mannan specifically acted on endothelial and Kupffer cells.
The uptake of 1251-asialotransferrin by hepatocytes was inhibited more than 52% by preinjection of GalNAc (Fig. 8) . It must be kept in mind that the association of transferrin with the cells is about 30% of that of asialotransferrin, so that the maximal sugar-mediated inhibition will be 70% . Similarly, as with 1251-asialofetuin, GalNAc does not affect the interaction of 1251-asialotransferrin with endothelial or Kupffer cells whereas with these latter cell types mannan is specifically effective.
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DISCUSSION
The data indicate that with the present liver cell-isolation procedure, it is possible to determine in vivo the specific interaction of transferrin and asialotransferrin with the various liver cell types. The specific interaction of transferrin with the liver endothelial and Kupffer cells per mg of cell protein was found to be at least 10-fold higher than with the parenchymal cells.
However, because these cell types only contain 3.3% and 2.5% respectively of the liver protein (Van Berkel et al., 1985a,b) Soda & Tavassoli (1984) and Kishimoto & Tavassoli (1985) suggested that only liver endothelial cells should possess transferrin receptors. The maximal number of binding sites for transferrin found with isolated hepatocytes varies between zero and 162000 per cell (Young & Aisen, 1980; Cole & Glass, 1983; Morley & Bezkorovainy, 1983; Thorstensen & Romslo, 1984; Tei et al., 1984) , while in a perfused liver system approximately double this number can be calculated if the binding is assumed to be confined to hepatocytes (Morgan et al., 1986) . The presence of about half the transferrin receptors in non-parenchymal cells can perfectly explain these discrepancies. The involvement ofa high-affinity site on parenchymal, endothelial and Kupffer cells responsible for the interaction with the transferrin in vivo is indicated by the inhibitory effect of an excess of unlabelled transferrin. Furthermore, the high-affinity recognition of transferrin is coupled to iron delivery in all three cell types, with kinetics consistent with separate iron uptake pathways in the various cell types. This contrasts with earlier suggestions for iron delivery to parenchymal cells, for which transcytosis through endothelial cells was suggested to be obligatory (Soda & Tavassoli, 1984; Kishimoto & Tavassoli, 1985) . However, it must be remembered that liver parenchymal cells have direct access to the blood compartment, because liver endothelial cells possess fenestrations ofabout 100 nm (Wisse, 1970) , allowing free exchange of sinusoidal blood components to the space of Disse. The quantitative aspects of 59Fe uptake in the isolated cells must however be interpreted cautiously because, in contrast with the apoprotein, part of the 59Fe is apparently lost from the cells during the cell isolation procedure.
The increased fraction of desialylated transferrin which becomes associated with the liver cells is thought to be mediated by a receptor which also recognizes asialofetuin with a high affinity (Ashwell & Morell, 1974) . Indeed, we found that an excess of asialofetuin completely abolished the increased interaction of asialotransferrin with the various liver cells. However, the increased interaction of asialotransferrin as compared with transferrin with the endothelial and Kupffer cells was quite unexpected and competition experiments with various sugars were necessary to evaluate the recognition specificity. The increased interaction of asialotransferrin with parenchymal cells was specifically inhibited by GalNAc and not affected by GlcNAc or mannan. A similar inhibitory specificity was noticed with 1251-asialofetuin, indicating that the recognition of asialotransferrin by liver parenchymal cells is mediated by a galactose-specific receptor. However, neither the interaction of asialotransferrin nor asialofetuin with Kupffer and endothelial cells was affected by GalNAc. These data also rule out the possibility that galactose receptors from non-parenchymal cells (Kolb-Bachofen et al., 1982) do interact with asialotransferrin or asialofetuin. However, these cell types do possess mannose-specific receptors (Steer & Clarenburg, 1979; Achord et al., 1978) and competition experiments with mannan indeed indicate the involvement of mannose groups in the interaction of asialotransferrin and asialofetuin with Kupffer and endothelial cells, so also explaining the inhibitory effect of asialofetuin on asialotransferrin binding to these latter cell types (Fig. 6) . It is well known that sialic acid removal from carbohydrate chains not only exposes terminal galactose groups for receptor recognition but also subterminal carbohydrate chain components (Hubbard et al., 1979) . So the similar subterminal presence of mannose units in asialotransferrin and asialofetuin results in an increased interaction of these ligands with the Kupffer and endothelial liver cells.
The increased fraction of asialotransferrin, as compared with transferrin, which becomes associated with the various liver cells, also leads to an increased 59Fe delivery. Studies with isolated hepatocytes in vitro indicated that asialotransferrin and asialofetuin segregate from each other, after cellular uptake, with asialofetuin transport to lysosomes and asialotransferrin recycling to the cell surface (Regoeczi & Debanne, 1981; Tolleshaug, 1984) . Our present data in vivo indicate that the increased iron delivery of asialotransferrin to the liver as compared with transferrin does not lead to an equivalent lower serum percentage of 125I-asialotransferrin, so suggesting that also in vivo 1251-asialotransferrin can be released from the liver again after cellular delivery of its iron.
In conclusion, it can be stated that the interaction of transferrin and asialotransferrin with the liver involves the concerted action of parenchymal, Kupffer and endothelial liver cells, leading to the necessity of including the multiple cellular interaction sites in future studies on the role of the liver in (asialo)transferrin metabolism.
